Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trial Of Asians Shows GSK Bird Flu Vaccine Fights Several Strains

This article was originally published in PharmAsia News

Executive Summary

An Asia-based trial of a GlaxoSmithKline vaccine suggests it may be effective against some of the strains of the H5N1 avian flu virus, according to the U.K. company. The trial of 1,206 adults showed they produced antibodies that neutralized the viral strain found in Vietnam and one detected in Indonesia, even though the vaccine was based on the Vietnam strain. Participants in the study included people in Hong Kong, Singapore, Taiwan and Thailand. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts